XML 47 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Warrants
 12 Months Ended
Dec. 31, 2022
Schedule Of Warrants Activity  
Warrants

23. Warrants

 

During the year ended December 31, 2022, an aggregate of 250,121 warrants were exercised primarily on a cashless basis for 73,321 common shares, and 1,599,179 Reg-A public offering and private placement warrants expired.

 

During the year ended December 31, 2021, a total of 2,488,721 warrants were exercised for 2,287,511 common shares. 1,637,709 warrants were exercised at $4.00 per share, 317,000 warrants were exercised at $6.05 per share, and 494,500 warrants were exercised on a cashless basis for 293,290 common shares. During the same period, the 39,512 warrants were exercised on a cashless basis related to a convertible promissory note (please refer to note 10). For the year ended December 31, 2021, 2,287,511 common shares were issued from warrant exercises.

 

During the year ended December 31, 2021, the Company issued 1,502,409 and 2,040,990 warrants convertible to 1 and 2 common shares each exercisable for a period of 12 and 18 months, respectively. The warrants were issued in connection with the Reg-A public offering and private placement offering, respectively. The exercise price of the warrants is $4.00 per share. During the year ended December 31, 2022, the Company and a warrant holder reached an agreement to extend the exercisable period of 300,000 warrants, convertible to 2 common shares each, for an additional 12 months. During 2021, the Company issued 3,763,636 warrants convertible to 1 common share at an exercise price of $6.05 per share exercisable for a period of 36 months. 3,272,727 warrants were purchased through the underwritten public offering and 490,909 over-allotment warrants were purchased by the underwriter. The warrants were issued in connection with the underwritten public offering.

 

During the year ended December 31, 2021, the Company and warrant holder reached an agreement to amend a previous warrant agreement. The Company issued an additional 150,000 warrants for a total of 250,000 warrants valued at $37,000. The exercisable period of the warrants was also amended to a period of five years beginning on January 14, 2021. The warrants are convertible to 1 common share each exercisable at $2 per share. During the year ended December 31, 2022, the warrants were exercised on a cashless basis for 73,321 common shares.

 

 

Worksport Ltd.

Notes to the Consolidated Financial Statements

December 31, 2022 and 2021

 

23. Warrants (continued)

 

During the year ended December 31, 2021, the Company issued 130,909 representative warrants to the Company’s underwriters. The representative warrants are not exercisable until January 30, 2022. The representative warrants are exercisable for 130,909 common shares at $6.05 per share until August 3, 2024. As of December 31, 2022, the Company recognized a value of $273,993 for the representative warrants to share issuance cost.

 

During the year ended December 31, 2021, 26,815 warrants expired.

 

As of December 31, 2022, the Company has the following warrants outstanding:

 

Exercise price   Number outstanding   Remaining Contractual Life (Years)   Expiry date
$4.00    300,000    1.22   December 31, 2024
$6.05    3,446,515    1.60   August 3, 2024
$6.05    130,909    1.59   August 6, 2024
$2.40    62,500    2.22   March 20, 2025
      3,939,924    1.58    

 

   December 31, 2022   December 31, 2021 
   Number of warrants   Weighted average price   Number of warrants   Weighted average price 
Balance, beginning of year   5,652,827   $5.14    716,815   $3.46 
Issuance   130,909   $6.05    7,457,036   $4.99 
Expired   (1,593,691)  $(4.00)   (26,815)  $4.00 
Exercise   (250,121)  $(2.00)   (2,494,209)  $4.22 
Balance, end of period   3,939,924   $5.84    5,652,827   $5.14